RU2011103183A - Дифференцирование плюрипотентных стволовых клеток - Google Patents
Дифференцирование плюрипотентных стволовых клеток Download PDFInfo
- Publication number
- RU2011103183A RU2011103183A RU2011103183/10A RU2011103183A RU2011103183A RU 2011103183 A RU2011103183 A RU 2011103183A RU 2011103183/10 A RU2011103183/10 A RU 2011103183/10A RU 2011103183 A RU2011103183 A RU 2011103183A RU 2011103183 A RU2011103183 A RU 2011103183A
- Authority
- RU
- Russia
- Prior art keywords
- amino acid
- point mutation
- stem cells
- pluripotent stem
- activin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Abstract
1. Способ дифференцирования плюрипотентных стволовых клеток в клетки, экспрессирующие маркеры, характерные для линии сформированной эндодермы, состоящий в обработке плюрипотентных стволовых клеток средой, содержащей пептид с аминокислотной последовательностью активин А, имеющей по меньшей мере одну точечную мутацию, в течение периода времени, достаточного для того, чтобы плюрипотентные стволовые клетки дифференцировались в клетки, экспрессирующие маркеры, характерные для линии сформированной эндодермы. !2. Способ по п.1, в котором указанные плюрипотентные стволовые клетки представляют собой эмбриональные стволовые клетки. ! 3. Способ по п.1, в котором по меньшей мере одну точечную мутацию вводят в аминокислотную последовательность активина А по месту по меньшей мере одного аминокислотного остатка, выбираемого из группы, состоящей из: 10I, 16F, 39Y, 41E, 43E, 74F, 75A, 76N, 77L, 78K, 79S и 82V. ! 4. Способ по п.3, в котором указанную по меньшей мере одну точечную мутацию выбирают из группы, состоящей из: делеции, инсерции и замены. ! 5. Способ по п.1, в котором по меньшей мере одну точечную мутацию вводят в аминокислотную последовательность активина А по месту по меньшей мере одного аминокислотного остатка, выбираемого из группы, состоящей из: 16F, 18V, 19S, 20F, 37A, 38N, 39Y, 41E, 74F, 82V, 107N, 109I, 110V и 116S. ! 6. Способ по п.5, в котором указанную по меньшей мере одну точечную мутацию выбирают из группы, состоящей из: делеции, инсерции и замены. ! 7. Способ по п.1, в котором пептид, содержащий аминокислотную последовательность активина А, содержащую по меньшей мере одну точечную мутацию, подвергается дальнейшей модификации для включения по меньшей мере одного участка
Claims (9)
1. Способ дифференцирования плюрипотентных стволовых клеток в клетки, экспрессирующие маркеры, характерные для линии сформированной эндодермы, состоящий в обработке плюрипотентных стволовых клеток средой, содержащей пептид с аминокислотной последовательностью активин А, имеющей по меньшей мере одну точечную мутацию, в течение периода времени, достаточного для того, чтобы плюрипотентные стволовые клетки дифференцировались в клетки, экспрессирующие маркеры, характерные для линии сформированной эндодермы.
2. Способ по п.1, в котором указанные плюрипотентные стволовые клетки представляют собой эмбриональные стволовые клетки.
3. Способ по п.1, в котором по меньшей мере одну точечную мутацию вводят в аминокислотную последовательность активина А по месту по меньшей мере одного аминокислотного остатка, выбираемого из группы, состоящей из: 10I, 16F, 39Y, 41E, 43E, 74F, 75A, 76N, 77L, 78K, 79S и 82V.
4. Способ по п.3, в котором указанную по меньшей мере одну точечную мутацию выбирают из группы, состоящей из: делеции, инсерции и замены.
5. Способ по п.1, в котором по меньшей мере одну точечную мутацию вводят в аминокислотную последовательность активина А по месту по меньшей мере одного аминокислотного остатка, выбираемого из группы, состоящей из: 16F, 18V, 19S, 20F, 37A, 38N, 39Y, 41E, 74F, 82V, 107N, 109I, 110V и 116S.
6. Способ по п.5, в котором указанную по меньшей мере одну точечную мутацию выбирают из группы, состоящей из: делеции, инсерции и замены.
7. Способ по п.1, в котором пептид, содержащий аминокислотную последовательность активина А, содержащую по меньшей мере одну точечную мутацию, подвергается дальнейшей модификации для включения по меньшей мере одного участка, способного специфически связываться с лигандом, находящимся на твердом субстрате в колонке для аффинной очистки.
8. Способ по п.7, в котором по меньшей мере один участок, способный специфически связываться с лигандом, находящимся на твердом субстрате в колонке для аффинной очистки, представляет собой сайт связывания с металлом.
9. Способ по п.8, в котором сайт связывания с металлом содержит пару остатков гистидина.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7688908P | 2008-06-30 | 2008-06-30 | |
US61/076,889 | 2008-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2011103183A true RU2011103183A (ru) | 2012-08-10 |
Family
ID=41226604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011103183/10A RU2011103183A (ru) | 2008-06-30 | 2009-06-29 | Дифференцирование плюрипотентных стволовых клеток |
Country Status (11)
Country | Link |
---|---|
US (1) | US20110091971A1 (ru) |
EP (1) | EP2318516A1 (ru) |
JP (1) | JP2011526784A (ru) |
KR (1) | KR20110025220A (ru) |
CN (2) | CN108486040A (ru) |
AU (1) | AU2009267167A1 (ru) |
BR (1) | BRPI0913925A2 (ru) |
CA (1) | CA2729734A1 (ru) |
MX (1) | MX2011000123A (ru) |
RU (1) | RU2011103183A (ru) |
WO (1) | WO2010002785A1 (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2011103183A (ru) * | 2008-06-30 | 2012-08-10 | Сентокор Орто Байотек Инк. (Us) | Дифференцирование плюрипотентных стволовых клеток |
US8268621B2 (en) * | 2008-12-03 | 2012-09-18 | International Stem Cell Corporation | Methods of deriving definitive endoderm cells from pluripotent parthenogenetic stem cells |
EP2723852B1 (en) | 2011-06-21 | 2021-11-17 | Novo Nordisk A/S | Efficient induction of definitive endoderm from pluripotent stem cells |
JP6469003B2 (ja) * | 2012-06-08 | 2019-02-13 | ヤンセン バイオテツク,インコーポレーテツド | 膵内分泌細胞へのヒト胚性幹細胞の分化 |
GB201216796D0 (en) * | 2012-09-20 | 2012-11-07 | Cambridge Entpr Ltd | In vitro pancreatic differentiation |
ES2942484T3 (es) | 2012-12-31 | 2023-06-01 | Janssen Biotech Inc | Diferenciación de células madre embrionarias humanas en células endocrinas pancreáticas usando reguladores de HB9 |
ES2837763T3 (es) | 2012-12-31 | 2021-07-01 | Janssen Biotech Inc | Cultivo de células madre embrionarias humanas en la interconexión aire-líquido para la diferenciación en células endocrinas pancreáticas |
GB201317869D0 (en) | 2013-10-09 | 2013-11-20 | Cambridge Entpr Ltd | In vitro production of foregut stem cells |
CA2949056A1 (en) | 2014-05-16 | 2015-11-19 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
MA45502A (fr) | 2016-06-21 | 2019-04-24 | Janssen Biotech Inc | Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases |
KR102201417B1 (ko) * | 2018-05-02 | 2021-01-11 | (주) 에스바이오메딕스 | 도파민 신경세포의 분리방법 및 이를 이용하여 분리된 도파민 신경세포를 포함하는 파킨슨병 치료용 약제학적 조성물 |
CA3139292A1 (en) | 2019-05-31 | 2020-12-03 | Timothy M. BRUHN | Cell encapsulation devices with controlled oxygen diffusion distances |
JP2022535239A (ja) | 2019-05-31 | 2022-08-05 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 生体適合性メンブレン複合体 |
US20220370184A1 (en) | 2019-05-31 | 2022-11-24 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
AU2020282355B2 (en) | 2019-05-31 | 2023-11-02 | Viacyte, Inc. | A biocompatible membrane composite |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3935067A (en) * | 1974-11-22 | 1976-01-27 | Wyo-Ben Products, Inc. | Inorganic support for culture media |
US4557264A (en) * | 1984-04-09 | 1985-12-10 | Ethicon Inc. | Surgical filament from polypropylene blended with polyethylene |
US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US5837539A (en) * | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5449383A (en) * | 1992-03-18 | 1995-09-12 | Chatelier; Ronald C. | Cell growth substrates |
US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
GB9310557D0 (en) * | 1993-05-21 | 1993-07-07 | Smithkline Beecham Plc | Novel process and apparatus |
US6703017B1 (en) * | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US6001647A (en) * | 1994-04-28 | 1999-12-14 | Ixion Biotechnology, Inc. | In vitro growth of functional islets of Langerhans and in vivo uses thereof |
US5718922A (en) * | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
US5908782A (en) * | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
EP1028737B1 (en) * | 1997-07-03 | 2007-04-04 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
PT1066052E (pt) * | 1998-03-18 | 2006-06-30 | Osiris Therapeutics Inc | Celulas estaminais mesenquimatosas para a prevencao e tratamento |
US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6815203B1 (en) * | 1999-06-23 | 2004-11-09 | Joslin Diabetes Center, Inc. | Methods of making pancreatic islet cells |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US7005252B1 (en) * | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
US6436704B1 (en) * | 2000-04-10 | 2002-08-20 | Raven Biotechnologies, Inc. | Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
CA2413910A1 (en) * | 2000-06-26 | 2002-12-27 | Renomedix Institute Inc. | Cell fractions containing cells capable of differentating into neural cells |
JP2004527249A (ja) * | 2001-04-19 | 2004-09-09 | デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング | 幹細胞をインスリン産生細胞に分化する方法 |
US6617152B2 (en) * | 2001-09-04 | 2003-09-09 | Corning Inc | Method for creating a cell growth surface on a polymeric substrate |
US20030138951A1 (en) * | 2001-10-18 | 2003-07-24 | Li Yin | Conversion of liver stem and progenitor cells to pancreatic functional cells |
GB2415432B (en) * | 2001-12-07 | 2006-09-06 | Geron Corp | Islet cells from human embryonic stem cells |
WO2003087349A1 (fr) * | 2002-04-17 | 2003-10-23 | Otsuka Pharmaceutical Co., Ltd. | Methode de formation de cellules pancreatiques $g(b) a partir de cellules mesenchymales |
US20040161419A1 (en) * | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
JP2005531609A (ja) * | 2002-06-05 | 2005-10-20 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | キナーゼ阻害剤としてのシスインドリル−マレイミド誘導体 |
US7838290B2 (en) * | 2002-07-25 | 2010-11-23 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
US7371576B2 (en) * | 2002-09-06 | 2008-05-13 | Reneuron, Inc. | CD56 positive human adult pancreatic endocrine progenitor cells |
US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US20070154981A1 (en) * | 2003-02-14 | 2007-07-05 | The Board Of Trustees Of The Leland Stanford Junior University | Insulin-producing cells derived from stem cells |
US20060194315A1 (en) * | 2003-03-31 | 2006-08-31 | Condie Brian G | Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
US20090203141A1 (en) * | 2003-05-15 | 2009-08-13 | Shi-Lung Lin | Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents |
AU2004252567B2 (en) * | 2003-06-27 | 2011-10-06 | Ethicon, Incorporated | Repair and regeneration of ocular tissue using postpartum-derived cells |
IL161903A0 (en) * | 2003-07-17 | 2005-11-20 | Gamida Cell Ltd | Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
US7157275B2 (en) * | 2003-08-15 | 2007-01-02 | Becton, Dickinson And Company | Peptides for enhanced cell attachment and growth |
US20070212732A1 (en) * | 2003-08-27 | 2007-09-13 | Nobuko Uchida | Enriched Pancreatic Stem Cell and Progenitor Cell Populations, and Methods for Identifying, Isolating and Enriching for Such Populations |
US7468391B2 (en) * | 2003-12-17 | 2008-12-23 | Allergan, Inc. | Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B |
US20060030042A1 (en) * | 2003-12-19 | 2006-02-09 | Ali Brivanlou | Maintenance of embryonic stem cells by the GSK-3 inhibitor 6-bromoindirubin-3'-oxime |
CN103898047B (zh) * | 2003-12-23 | 2020-03-03 | 维亚希特公司 | 定形内胚层 |
TWI334443B (en) * | 2003-12-31 | 2010-12-11 | Ind Tech Res Inst | Method of single cell culture of undifferentiated human embryonic stem cells |
WO2005071066A1 (en) * | 2004-01-23 | 2005-08-04 | Board Of Regents, The University Of Texas System | Methods and compositions for preparing pancreatic insulin secreting cells |
EP1737944A4 (en) * | 2004-03-09 | 2010-03-24 | Lifescan Inc | METHOD FOR GENERATING INSULIN-PRODUCING CELLS |
WO2005086845A2 (en) * | 2004-03-10 | 2005-09-22 | Regents Of The University Of California | Compositions and methods for growth of embryonic stem cells |
JP4491014B2 (ja) * | 2004-04-01 | 2010-06-30 | ウイスコンシン アラムニ リサーチ ファンデーション | 幹細胞の内胚葉および膵臓系統への分化 |
DK1740612T3 (da) * | 2004-04-27 | 2019-10-07 | Viacyte Inc | Pdx1 udtrykkende endoderm |
US20080268533A1 (en) * | 2004-08-25 | 2008-10-30 | University Of Georgia Research Foundation, Inc. | Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells |
DE102004043256B4 (de) * | 2004-09-07 | 2013-09-19 | Rheinische Friedrich-Wilhelms-Universität Bonn | Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension |
US7442548B2 (en) * | 2004-09-08 | 2008-10-28 | Wisconsin Alumni Research Foundation | Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid |
NZ553241A (en) * | 2004-09-08 | 2009-11-27 | Wisconsin Alumni Res Found | Medium and culture of pluripotent stem cells |
EP1859026A2 (en) * | 2005-01-31 | 2007-11-28 | ES Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
DK2420565T3 (en) * | 2006-02-23 | 2017-12-04 | Viacyte Inc | APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS |
US7695965B2 (en) * | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
DK1999253T3 (da) * | 2006-03-02 | 2019-08-12 | Viacyte Inc | Endokrine precursorceller, pankreatiske hormon-udtrykkende celler og fremgangsmåder til fremstilling |
US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
AU2007277364B2 (en) * | 2006-07-26 | 2010-08-12 | Viacyte, Inc. | Methods of producing pancreatic hormones |
WO2008039521A2 (en) * | 2006-09-26 | 2008-04-03 | Nmt Medical, Inc. | Method for modifying a medical implant surface for promoting tissue growth |
JP2011514169A (ja) * | 2008-03-17 | 2011-05-06 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 幹細胞培養のためのマイクロキャリア |
US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
RU2011103183A (ru) * | 2008-06-30 | 2012-08-10 | Сентокор Орто Байотек Инк. (Us) | Дифференцирование плюрипотентных стволовых клеток |
KR101829310B1 (ko) * | 2008-06-30 | 2018-02-14 | 얀센 바이오테크 인코포레이티드 | 만능 줄기 세포의 분화 |
US8008075B2 (en) * | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
-
2009
- 2009-06-29 RU RU2011103183/10A patent/RU2011103183A/ru not_active Application Discontinuation
- 2009-06-29 AU AU2009267167A patent/AU2009267167A1/en not_active Abandoned
- 2009-06-29 CN CN201810244535.1A patent/CN108486040A/zh active Pending
- 2009-06-29 CA CA2729734A patent/CA2729734A1/en not_active Abandoned
- 2009-06-29 JP JP2011516763A patent/JP2011526784A/ja active Pending
- 2009-06-29 BR BRPI0913925-7A patent/BRPI0913925A2/pt not_active Application Discontinuation
- 2009-06-29 WO PCT/US2009/049049 patent/WO2010002785A1/en active Application Filing
- 2009-06-29 US US12/493,741 patent/US20110091971A1/en not_active Abandoned
- 2009-06-29 EP EP20090774236 patent/EP2318516A1/en not_active Withdrawn
- 2009-06-29 KR KR1020117001977A patent/KR20110025220A/ko not_active Application Discontinuation
- 2009-06-29 MX MX2011000123A patent/MX2011000123A/es active IP Right Grant
- 2009-06-29 CN CN200980134985.4A patent/CN102171330B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102171330B (zh) | 2018-04-20 |
WO2010002785A1 (en) | 2010-01-07 |
JP2011526784A (ja) | 2011-10-20 |
US20110091971A1 (en) | 2011-04-21 |
CA2729734A1 (en) | 2010-01-07 |
CN108486040A (zh) | 2018-09-04 |
MX2011000123A (es) | 2011-02-25 |
AU2009267167A1 (en) | 2010-01-07 |
BRPI0913925A2 (pt) | 2015-08-04 |
CN102171330A (zh) | 2011-08-31 |
KR20110025220A (ko) | 2011-03-09 |
EP2318516A1 (en) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011103183A (ru) | Дифференцирование плюрипотентных стволовых клеток | |
Ebrahimi | Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency | |
Guzzo et al. | Efficient differentiation of human iPSC‐derived mesenchymal stem cells to chondroprogenitor cells | |
Teven et al. | Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation | |
Xie et al. | Characterization of nestin, a selective marker for bone marrow derived mesenchymal stem cells | |
CN109554350B (zh) | 用于胎儿血红蛋白再诱导的靶向bcl11a远端调控元件 | |
Maki et al. | Expression of stem cell pluripotency factors during regeneration in newts | |
Dahl et al. | Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells | |
ES2484919T3 (es) | Métodos que usan polipéptidos que tienen actividad de hidrolasa | |
Wiedemann et al. | Induced pluripotent stem cells generated from adult bone marrow–derived cells of the nonhuman primate (callithrix jacchus) using a novel quad-cistronic and excisable lentiviral vector | |
Neff et al. | Dedifferentiation and the role of sall4 in reprogramming and patterning during amphibian limb regeneration | |
DE602005012233D1 (de) | Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren | |
Chen et al. | Heterochromatin loosening by the Oct4 linker region facilitates Klf4 binding and iPSC reprogramming | |
TN2009000182A1 (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
SG157366A1 (en) | High temperature corrosion inhibitor | |
DE602005014072D1 (de) | Verfahren zur Entfernung von Maschinenablagerungen von Turbinenbauteilen und dafür zuverwendende Zusammensetzung | |
Liao et al. | Functions of DNA methyltransferase 3‐like in germ cells and beyond | |
Saidi et al. | Dynamic changes of epigenetic signatures during chondrogenic and adipogenic differentiation of mesenchymal stem cells | |
Wakao et al. | Basic characteristics of muse cells | |
Bhartiya et al. | Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer | |
Longo et al. | PTHrP in differentiating human mesenchymal stem cells: Transcript isoform expression, promoter methylation, and protein accumulation | |
Bi et al. | Meat Science and Muscle Biology Symposium: Stem cell niche and postnatal muscle growth | |
Somal et al. | Impact of cryopreservation on caprine fetal adnexa derived stem cells and its evaluation for growth kinetics, phenotypic characterization, and wound healing potential in xenogenic rat model | |
Bossù et al. | Today prospects for tissue engineering therapeutic approach in dentistry | |
Gupta et al. | Do stem cells exist in the adult kidney? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20140701 |